Cyprotex
the in-vitro ADMET and high-content-toxicology leader (Macclesfield, UK), now within Labcorp — its devTOX quickPredict human-iPSC developmental-toxicity assay and miniaturised 96-well CYP induction workflows were both presented in 2026,…
- Country
- United Kingdom
Commercial
GLP / OECD
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Toxics screening (toxicomics, service) | bioinformatics-omics | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.